Why don’t we have an early detection test for ovarian cancer? Will we ever have one? Should everyone be screened for ovarian cancer? Our panel of experts and survivors tackle tough questions you have on these important issues. Presented by Deborah Armstrong, MD, Director, Breast and Ovarian Surveillance Service, Johns Hopkins Medicine; Philip Castle, PhD, MPH, Director of the Division of Cancer Prevention (DCP), National Cancer Institute (NCI); Annie Ellis, Annie Ellis, OCRA and SHARE; Audra Moran, President & CEO, OCRA.
